Cornerstone Investment Partners LLC reduced its stake in shares of Stryker Corporation (NYSE:SYK) by 0.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,499 shares of the medical technology company’s stock after selling 47 shares during the period. Cornerstone Investment Partners LLC’s holdings in Stryker Corporation were worth $1,041,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Washington Trust Bank increased its position in Stryker Corporation by 16.8% in the first quarter. Washington Trust Bank now owns 3,567 shares of the medical technology company’s stock valued at $470,000 after buying an additional 513 shares during the last quarter. DnB Asset Management AS increased its position in Stryker Corporation by 13.9% in the first quarter. DnB Asset Management AS now owns 36,795 shares of the medical technology company’s stock valued at $4,844,000 after buying an additional 4,500 shares during the last quarter. Mitchell Sinkler & Starr PA increased its position in Stryker Corporation by 34.6% in the first quarter. Mitchell Sinkler & Starr PA now owns 3,110 shares of the medical technology company’s stock valued at $409,000 after buying an additional 800 shares during the last quarter. Nisa Investment Advisors LLC increased its position in Stryker Corporation by 0.3% in the first quarter. Nisa Investment Advisors LLC now owns 117,041 shares of the medical technology company’s stock valued at $15,408,000 after buying an additional 380 shares during the last quarter. Finally, Whitnell & Co. increased its position in Stryker Corporation by 35.5% in the first quarter. Whitnell & Co. now owns 4,200 shares of the medical technology company’s stock valued at $553,000 after buying an additional 1,100 shares during the last quarter. Hedge funds and other institutional investors own 73.79% of the company’s stock.

Shares of Stryker Corporation (NYSE:SYK) traded up 0.25% on Tuesday, reaching $145.50. The company had a trading volume of 531,173 shares. The company’s 50-day moving average is $144.79 and its 200-day moving average is $136.72. Stryker Corporation has a one year low of $106.48 and a one year high of $148.84. The company has a market capitalization of $54.43 billion, a PE ratio of 32.48 and a beta of 0.80.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.51 by $0.02. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The company had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.98 billion. During the same period in the prior year, the firm earned $1.39 earnings per share. Stryker Corporation’s revenue was up 6.1% on a year-over-year basis. Equities research analysts predict that Stryker Corporation will post $6.50 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be paid a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s payout ratio is currently 37.95%.

TRADEMARK VIOLATION NOTICE: “Stryker Corporation (SYK) Shares Sold by Cornerstone Investment Partners LLC” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark legislation. The correct version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/08/22/stryker-corporation-syk-shares-sold-by-cornerstone-investment-partners-llc.html.

Several equities analysts have recently commented on the company. Cowen and Company reaffirmed a “buy” rating and issued a $160.00 target price (up previously from $150.00) on shares of Stryker Corporation in a research report on Sunday, July 30th. Zacks Investment Research downgraded Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, August 17th. BidaskClub raised Stryker Corporation from a “hold” rating to a “buy” rating in a research report on Thursday, August 17th. Stifel Nicolaus upped their target price on Stryker Corporation from $151.00 to $158.00 and gave the company a “buy” rating in a research report on Friday, July 28th. Finally, Oppenheimer Holdings, Inc. set a $148.00 target price on Stryker Corporation and gave the company a “hold” rating in a research report on Friday, July 28th. Three analysts have rated the stock with a sell rating, seven have given a hold rating and twelve have assigned a buy rating to the stock. Stryker Corporation has a consensus rating of “Hold” and an average price target of $144.03.

In other Stryker Corporation news, insider Lonny J. Carpenter sold 5,000 shares of the company’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the sale, the insider now owns 88,207 shares in the company, valued at $12,909,976.52. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of the company’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total transaction of $164,396.24. Following the completion of the sale, the insider now owns 8,983 shares in the company, valued at approximately $1,313,853.58. The disclosure for this sale can be found here. Over the last three months, insiders sold 32,810 shares of company stock valued at $4,754,958. 7.40% of the stock is owned by insiders.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.